In gynecology, denosumab is primarily used for the management of osteoporosis in postmenopausal women. Osteoporosis is a common condition in postmenopausal women due to the decrease in estrogen levels, which leads to increased bone resorption and decreased bone density. Denosumab helps to mitigate this process and reduce the risk of fractures.
